Form 4: IonQ Director Exercises Options and Sells Shares Under Pre-Arranged Trading Plan

IonQ Director Kathryn K. Chou exercised stock options and subsequently sold a portion of her shares on June 11, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Summary

• Kathryn K. Chou, a Director of IonQ, Inc., engaged in transactions involving the company's common stock.
• On June 11, 2025, Ms. Chou exercised options to acquire 14,000 shares of common stock at an exercise price of $4.61 per share.
• Concurrently, she sold 25,696 shares of common stock at a weighted average price of $40.4642 per share, with individual sales ranging from $39.03 to $43.69.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 12, 2025.
• Following these transactions, Ms. Chou beneficially owns 62,115 shares of common stock directly and 49,900 stock options.
• The stock option exercised was part of an original grant of 63,900 shares, vesting in three equal annual installments commencing July 11, 2023.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (option exercise and sale) conducted under a pre-arranged trading plan, which is a neutral event for the company's operational or financial performance.

Positives

• Director exercised options, indicating a realization of value from their compensation.
• Shares were sold at a significant premium ($40.4642 weighted average) compared to the exercise price ($4.61), demonstrating substantial personal gain for the director.

Negatives

• A director sold a significant number of shares (25,696), which could be interpreted as a reduction in insider holdings, although it was pre-planned.

Risks

• Potential for misinterpretation of insider selling as a lack of confidence, though mitigated by the Rule 10b5-1 plan.

Future Outlook

NA

Industry Context

This Form 4 filing details an insider transaction and does not provide broader industry context or trends for the quantum computing sector.

Related Party Transactions

• Kathryn K. Chou, a Director of IonQ, Inc., engaged in the exercise of stock options and subsequent sale of common stock, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: May view the sale as a director taking profits, but the pre-arranged Rule 10b5-1 plan mitigates negative interpretations. The exercise of options slightly increases the number of outstanding shares.

Key Dates

Recommendation

Keywords

IonQ, IONQ, insider trading, Form 4, stock options, share sale, director, Rule 10b5-1 plan